Along with weight loss, Faubion’s study found that both groups of women on semaglutide drugs showed improvement in heart health measures like A1C (a marker for diabetes) and blood pressure, although ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Tagrisso with chemo significantly improved survival and progression-free outcomes versus Tagrisso alone in newly diagnosed ...

Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

Adjuvant camrelizumab and concurrent chemoradiotherapy can improve outcomes in patients with gallbladder cancer and extrahepatic cholangiocarcinoma.

When standard cancer treatments begin to fail, especially in aggressive or advanced stages, oncologists are increasingly ...

Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

SaveHealth reports ADHD is a complex, lifelong condition affecting focus and impulse control, often needing a mix of ...

Alicia Morgans, MD, MPH, discusses how the ARANOTE trial not only demonstrated clinical efficacy for the combination of ADT and darolutamide, but also highlighted key quality-of-life benefits that ...

Early combo therapy after a heart attack lowers cholesterol faster and cuts heart risks more than statins alone. (CREDIT: Africa Studio / Shutterstock) ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

Combination therapy in mHSPC has increased, improving overall survival compared with ADT monotherapy. No significant OS difference exists between ARPI and docetaxel combinations, but ARPI offers ...